Background {#Sec1}
==========

The prevalence of obesity is increasing worldwide and is becoming one of the most important health hazards \[[@CR1]\], as obesity is highly associated with increased overall morbidity and mortality \[[@CR2]\].

Obesity is defined with a body mass index (BMI; body weight in kilogram divided by the square of the height in meters (kg/m^2^)) of at least 30.0 kg/m^2^ \[[@CR3]\], whereas overweight is defined with a BMI of 25--29.9 kg/m^2^. Normal weight is characterized by a BMI ranging between 19 to 24.9 kg/m^2^ \[[@CR4]\]. In this context, BMI seems a valuable parameter to predict obesity-related disease risks in a wide range of populations \[[@CR2]\]. There are, however, some limitations: Firstly, risk assessment by BMI is less applicable in persons over 65 years of age because they generally have a higher body fat content for the same BMI. Secondly, the abdominal (central, visceral, android) type of obesity, which is more often seen in men, is associated with higher morbidity than the rather female type of gluteofemoral (peripheral, gynoid) obesity and, thirdly, the BMI cut-off points for overweight and obesity are too high for Asian people \[[@CR2]\]. In addition, current large studies have indicated that measurement of waist circumference (WC) or waist-to-hip-ratio (WHR) may be a better disease risk predictor than BMI \[[@CR5], [@CR6]\]. There is, however, currently intensive research and debate as to whether BMI, WC, WHR, or all of them should be used to assess disease risk \[[@CR2]\].

For the purpose of this systematic review, however, only BMI is the most frequently reported data of obesity in a large number of studies.

Adipose tissue contains usually 5-10 % macrophages, but the adipose tissue of obese patients shows up to 60 % macrophage infiltration \[[@CR4]\]. Adipocytes secrete bioactive molecules called adipokines, that can modify or trigger inflammation and fat metabolism locally or systemically as signaling molecules to liver, muscle and endothelium \[[@CR4]\]. Therefore, the adipose tissue can be considered as an important metabolically active endocrine organ \[[@CR4]\].

This explains how obesity acts as a risk factor for several chronic diseases: Hypertension, type 2 diabetes, dyslipidemia, and coronary heart disease are so closely related to obesity that obesity itself is often considered to be a systemic disease. This disease also affects dental health \[[@CR7]\]. Accordingly obese persons require attention of physicians and dentists \[[@CR2]\].

Among dental pathologies, periodontitis is a very common, primarily bacterial inflammatory disease, which destroys teeth surrounding soft tissues and bone. It leads to pocket formation and ultimately to loss of teeth if no effective treatment is applied \[[@CR8]\]. Periodontitis is no longer considered only an oral health issue but also a public health problem, as it constitutes a risk factor for cardiovascular conditions, poor glycemic control in diabetics and adverse outcome of pregnancy \[[@CR4], [@CR8]\]. These correlations coincide with obesity and general health.

Recently, it has been suggested that obesity is a possible risk factor for periodontitis \[[@CR8]\]. One study identified obesity even as the second strongest risk factor for periodontitis preceded only by smoking \[[@CR9]\]. The first report on the relationship between obesity and periodontal disease appeared in 1977. Perlstein and co-workers \[[@CR10]\] found greater alveolar bone resorption in obese than in non-obese rats. Under healthy oral conditions, obesity itself did not promote periodontal damage, but in the presence of bacterial plaque accumulation periodontal inflammation was more severe in obese than in non-obese animals. With concomitant arterial hypertension, plaque accumulation caused even more pronounced periodontal destruction than with obesity alone. These results suggest that a combination of risk factors, such as the one defined by the metabolic syndrome, elicit a more severe periodontal effect \[[@CR10], [@CR11]\]. Chaffee et al. \[[@CR12]\] found in their meta-analysis an increased prevalence odds ratio for obesity among subjects with periodontal disease of approximately one-third, a greater mean clinical attachment loss (CAL) among obese individuals, a higher BMI among subjects with periodontal disease, and a trend for linear increase in the odds of periodontal disease with increasing BMI \[[@CR4], [@CR12]\]. Finally the association reported between obesity and periodontitis was less strong than that reported between periodontal disease and adverse pregnancy outcomes \[[@CR12], [@CR13]\] or cardiovascular events \[[@CR12], [@CR14]\]. There seems, however, to be a stronger obesity-periodontitis association in women, non-smokers and younger individuals than in the general adult populations \[[@CR12]\]. In addition, smoking remains another well-studied predisposing factor for periodontitis \[[@CR12], [@CR15], [@CR16]\]. Thus, BMI and smoking share a complex relationship \[[@CR17]\]. This relationship can be inverse in certain populations \[[@CR12], [@CR18], [@CR19]\].

The biological mechanism by which obesity predisposes to periodontitis is not fully understood \[[@CR8]\]. Compared to individuals with normal weight individuals with obesity have higher levels of circulating tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), which are also secreted from adipose tissue and are involved in the pathophysiology of both obesity and periodontitis. Not surprisingly, serum levels of these cytokines decrease with loss of weight \[[@CR20]\].

The objective of this systematic review was to study the hypothesis whether the clinical outcome, in terms of pocket depth reduction, after non-surgical periodontal therapy in non-obese is better than in obese individuals. To verify this hypothesis, we systematically reviewed all retrievable, qualitatively adequate clinical investigations, which focused on this topic.

Methods {#Sec2}
=======

The review was conducted according to the PRISMA criteria \[[@CR21]\]. The research question was explored using the *PICO* method \[[@CR22]). The focused question addressed was:

Does non-surgical periodontal therapy (I) have a different outcome in obese chronic periodontitis patients (P), than in non-obese chronic periodontitis patients (C), regarding periodontal pocket depth reduction as the main clinical periodontal parameter (O).

Search strategy and review process {#Sec3}
----------------------------------

An electronic search of SCOPUS, MEDLINE, PubMed, Cochrane, CINAHL, Biosis and Web of Science was carried out considering articles published up to January 2016 in English or German language. The search was performed in two steps. The first electronic search started at 20.11.14 and an update has been done at 5.1.16.

This is shown in Table [1](#Tab1){ref-type="table"}. For the database search, a combination of subject headings (MeSH terms and CINAHL headings) and free text search was used. An example of a detailed strategy (Medline/OvidSP) is shown in Table [2](#Tab2){ref-type="table"}.Table 1Search protocols with the respective number of references dated from November 11 2014 (1) and January 1 2016 (2)References 1 & 2References after deduplication 1 & 2Scopus40 + 149 + 5Medline42 + 839 + 7PubMed6 + 112 + 11Cochrane12 + 22 + 1CINAHL48 + 1542 + 13Biosis25 + 710 + 1Web of Science38 + 1316 + 1Pool211 + 70120 + 39After deduplication 159 referencesTable 2Medline search strategyStepQueryHits1Exp Periodontitis/AND (adult OR chronic\*).ti,ab.57032Chronic periodontitis/OR periodontal pocket/700432 OR 3104544((adult OR chronic\*) adj3 periodontiti\*).ti,ab.53525(attachment adj3 loss).ti,ab. AND ((clinical OR periodontal) adj3 attachment).ti,ab.13056(periodontal adj3 pocket).ti,ab.10667OR/3-7129108Dental scaling/ OR "root planing"/34799((subgingival OR root OR supragingival) adj3 (scaling\* OR planing\*)).ti,ab.228810(deep adj3 (scaling\* OR cleaning)).ti,ab.6211((conventional OR inital OR "non surgical" OR non-surgical OR nonsurgical) adj3 (treatment OR therapy)).ti,ab.3341712OR/8-1137131137 AND 12218414Exp Obesity/15454015Exp Body Weight/36985016(overweight OR obese OR obesity OR adiposit\* OR BMI OR "body mass index").ti,ab.30084717(cardiolipin OR lipid\* OR leptin).ti,ab.39551718"waist to hip".ti,ab.904819(body adj3 weight).ti,ab.16376020OR/14-199542332113 AND 2042The asterisk represents a wildcard and can be used in all search fields that allow words and phrases

The same search protocol was applied to all databases.

Two of the authors (FAG, PRS) screened the titles for potential eligibility according to the inclusion criteria. Based on the abstract screening, 18 studies were selected for full text review. Scores were independently allocated by both authors to each publication according to their suitability for the present review (see inclusion criteria). Any discrepancies were resolved by consensus.

Inclusion criteria {#Sec4}
------------------

To be included studies had to be clinical interventional studies regarding the outcome of non-surgical periodontal therapy in obese or non-obese patients. The studies had to display the diagnosis of chronic periodontitis. Key parameters to be reported were data for pocket probing depth (PPD) and BMI.

Exclusion criteria {#Sec5}
------------------

Studies were excluded for the following reasons: animal studies, case reports, commentaries, unsuitable exposure or outcome measures, confounding medical diagnoses (e.g. pregnancy or any systemic disease, such as diabetes, in addition to metabolic syndrome), confounding *systemic* medical treatments such as immunosuppressive treatments, cortisone or antibiotic treatment as well as confounding *local* treatments such as treatment of peri-mucositis, gingival overgrowth or surgical periodontal treatment. Studies including either the diagnosis of aggressive periodontitis or of peri-implantitis were excluded as well.

Outcome measures {#Sec6}
----------------

The primary outcome measure is PPD after non-surgical periodontal treatment.

Data extraction {#Sec7}
---------------

A list with exclusion reasons for each paper was generated. Total number of patients, demographic data, origin of study, outcome measurements 2, 3, 6 and 12 months after therapy and the impact of obesity on the treatment-outcome were extracted. In addition, the exact definition of chronic periodontitis, the assessment of the periodontal disease and the number of smokers included in the studies were summarized. Data on the individual definition of obesity and the systemic examinations were also collected. Non-surgical periodontal treatment measures, treatment time, periodontal maintenance and adverse events were also recorded for each study separately (Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"}, [6](#Tab6){ref-type="table"} and [7](#Tab7){ref-type="table"}).Table 3Excluded studiesExcluded studiesReason for exclusionEuroperio 4 2003 \[[@CR37])Not addressing research questionAbstracts for the Royal Australian and New Zealand College of Psychiatrists 2005 \[[@CR38]\]Not addressing research question5th Joint Meeting of the European Tissue Repair Society and the Wound Healing Society 2009 \[[@CR39]\]Not addressing research questionRecently published abstracts \[[@CR40]\]Not addressing research questionDENTSPLY Posters 2012 \[[@CR41]\]Not addressing research questionHealthBeat 2007 \[[@CR42]\]Not addressing research questionAbstracts for Poster Presentations 2011 \[[@CR43]\]Not addressing research questionAbstracts for the International Symposium on Dental Hygiene 2013 \[[@CR44]\]Not addressing research questionAbou Sulaiman et al. 2010 \[[@CR45]\]Not addressing research questionAcharya et al. 2010 \[[@CR46]\]No PPD reduction dataAkpinar et al. 2013 \[[@CR47]\]Not addressing research questionAltay et al. 2013 \[[@CR20]\]No PPD reduction dataArmstrong et al. 2010 \[[@CR48]\]Not addressing research questionArora et al. 2013 \[[@CR49]\]Not addressing research questionBasegmez et al. 2011 \[[@CR50]\]Not addressing research questionBresolin et al. 2013 \[[@CR51]\]Not addressing research questionBresolin et al. 2014 \[[@CR52]\]Not addressing research questionCaspersen et al. 2012 \[[@CR53]\]Not addressing research questionCaula et al. 2014 \[[@CR54]\]No comparison*Caula* et al. 2014 \[[@CR54]\]DuplicateChapple et a. 2006 \[[@CR55]\]Not addressing research questionChapple et al. 2007 \[[@CR56]\]Not addressing research questionChandni et al. 2015 \[[@CR57]\]Not addressing research questionChaston et al. 2014 \[[@CR58]\]Not addressing research questionChee et al. 2008 \[[@CR59]\]Inclusion of diabetesChee et al. 2013 \[[@CR60]\]Missed intervention, inclusion of diabetesChen et al. 2012 \[[@CR61]\]Inclusion of diabetesD'Aiuto et al. 2004 \[[@CR62]\]Not addressing research questionD'Aiuto et al. 2004 \[[@CR63]\]Not addressing research questionD'Aiuto et al. 2005 \[[@CR23]\]No comparisonD'Aiuto et al. 2006 \[[@CR64]\]Not addressing research questionDeppe et al. 2010 \[[@CR65]\]Not addressing research questionDodington et al. 2015 \[[@CR66]\]No obesity dataDraper et al. 2010 \[[@CR67]\]Not addressing research questionDuan et al. 2009 \[[@CR24]\]Written in ChineseEdwards et al. 2006 \[[@CR68]\]Not addressing research questionEfurd et al. 2012 \[[@CR69]\]Not addressing research questionElliott-Smith et al. 2011 \[[@CR70]\]Not addressing research questionEngebretson et al. 2014 \[[@CR71]\]Not addressing research questionFairfield et al. 2010 \[[@CR72]\]Not addressing research questionFang et al. 2015 \[[@CR73]\]Inclusion of end-stage renal disease patientsFentoglu et al. 2010 \[[@CR74]\]Statin intakeFine et al. 2007 \[[@CR75]\]Not addressing research questionFokkema et al. 2012 \[[@CR76]\]Not addressing research questionFu et al. 2015 \[[@CR77]\]No comparisonGarcia et al. 2010 \[[@CR78]\]Not addressing research questionGiblin et al. 2014 \[[@CR79]\]Inclusion of prediabetesGiblin et al. 2014 \[[@CR79]\]DuplicateGluch et al. 2007 \[[@CR80]\]Inclusion of diabetesGoldie et al. 2002 \[[@CR81]\]Not addressing research questionGoldie et al. 2004 \[[@CR82]\]Not addressing research questionGoldie et al. 2005 \[[@CR83])Not addressing research questionGriffin et al. 2012 \[[@CR84]\]Not addressing research questionGurenlian et al. 2006 \[[@CR85]\]Not addressing research questionGurenlian et al. 2009 \[[@CR86]\]Not addressing research questionHammaker et al. 2010 \[[@CR87]\]Not addressing research questionHorwitz et al. 2007 \[[@CR88]\]Not addressing research questionHovliaras-Delozier et al. 2008 \[[@CR89]\]Not addressing research questionIde et al. 2004 \[[@CR90]\]No obesity dataIde et al. 2007 \[[@CR91]\]Not addressing research questionIwamoto et al. 2003 \[[@CR25]\]Application of antibioticsJahn et al. 2004 \[[@CR92]\]Not addressing research questionJahn et al. 2015 \[[@CR93]\]Not addressing research questionJaiswal et al. 2015 \[[@CR94]\]No treatment (SRP)Janket et al. 2014 \[[@CR95]\]Meta-analysisJanket et al. 2014 \[[@CR95]\]DuplicateJared et al. 2008 \[[@CR96]\]Not addressing research questionJared et al. 2008 \[[@CR96]\]DuplicateJiang et al. 2013 \[[@CR97]\]Not addressing research questionKamil et al. 2011 \[[@CR98]\]No obesity dataKamilov et al. 1998 \[[@CR99]\]Not addressing research questionKapellas et al. 2013 \[[@CR100]\]No obesity dataKardeşler et al. 2010 \[[@CR26]\]Inclusion of diabetesKeller et al. 2015 \[[@CR101]\]Systematic reviewKiany et al. 2014 \[[@CR102]\]No obesity dataKiany et al. 2015 \[[@CR103]\]DuplicateKipp et al. 2003 \[[@CR104]\]Not addressing research questionKudva et al. 2010 \[[@CR105]\]Inclusion of diabetesKumar et al. 2015 \[[@CR106]\]Inclusion of diabetesKurti et al. 2007 \[[@CR107]\]Not addressing research questionKurtis et al. 2007 \[[@CR108]\]DuplicateLee et al. 2014 \[[@CR109]\]Not addressing research questionLi et al. 2013 \[[@CR110]\]No obesity dataLing et al. 2012 \[[@CR111]\]Inclusion of diabetesLo et al. 2011 \[[@CR112]\]Not addressing research questionMalhotra et al. 2012 \[[@CR113]\]No obesity dataMancl et al. 2013 \[[@CR114]\]Not addressing research questionMartinez et al. 2014 \[[@CR115]\]Supplementation of ω-3 eicosapetaenoic acidMartinez et al. 2014 \[[@CR116]\]One year of omega-3 supplementationMatlock et al. 2012 \[[@CR117]\]No treatment (SRP)McDaniel et al. 2013 \[[@CR118]\]Not addressing research questionMeharwade et al. 2014 \[[@CR119]\]Local drug deliveryMerchant et al. 2014 \[[@CR120]\]Inclusion of diabetesMichalowicz et al. 2014 \[[@CR121]\]Inclusion of diabetesMizrak et al. 2006 \[[@CR122]\]Not addressing research questionMoeintaghavi et al. 2012 \[[@CR123]\]Inclusion of diabetesMoravec et al. 2011 \[[@CR124]\]No treatment (SRP)Muthu et al. 2015 \[[@CR125]\]No obesity dataNassar et al. 2012 \[[@CR126]\]Inclusion of diabetesNewton et al. 2011 \[[@CR127]\]Not addressing research questionNichols et al. 2001 \[[@CR128]\]Not addressing research questionNielsen et al. 2000 \[[@CR129]\]Not addressing research questionNovakovic et al. 2013 \[[@CR130]\]Not addressing research questionNovakovic et al. 2014 \[[@CR131]\]Not addressing research questionOliveira et al. 2011 \[[@CR132]\]Not addressing research questionOlsen et al. 2006 \[[@CR133]\]Not addressing research questionPaquette et al. 2008 \[[@CR134]\]Not addressing research questionPerayil et al. 2014 \[[@CR135]\]No obesity dataPerayil et al. 2014 \[[@CR136]\]DuplicatePhillips et al. 2013 \[[@CR137]\]Not addressing research questionPradeep et al. 2007 \[[@CR138]\]Not addressing research questionPrice et al. 2010 \[[@CR139]\]Not addressing research questionQiqiang et al. 2012 \[[@CR140]\]No obesity dataRadafshar et al. 2012 \[[@CR141]\]Not addressing research questionRadnai et al. 2009 \[[@CR142]\]Not addressing research questionRaghavendra et al. 2012 \[[@CR143]\]Not addressing research questionRamirez et al. 2011 \[[@CR144]\]No obesity dataRasch et al. 1995 \[[@CR145]\]Not addressing research questionSadatmansouri et al. 2006 \[[@CR146]\]Not addressing research questionSaffi et al. 2013 \[[@CR147]\]Inclusion of patients with coronary diseaseSaffi et al. 2013 \[[@CR147]\]DuplicateSaffi et al. 2014 \[[@CR148]\]Inclusion of patients with coronary artery diseaseShruti et al. 2010 \[[@CR27]\]No obesity dataSembene et al. 2000 \[[@CR149]\]Not addressing research questionSengupta et al. 1990 \[[@CR150]\]Not addressing research questionSgolastra et al. 2013 \[[@CR36]\]Meta-AnalysisShimada et al. 2010 \[[@CR151]\]No comparisonShimoe et al. 2011 \[[@CR152]\]Case reportSingh et al. 2014 \[[@CR153]\]Not addressing research questionSiqueira et al. 2013 \[[@CR154]\]Not addressing research questionStewart et al. 2001 \[[@CR155]\]Inclusion of diabetesTalbert et al. 2006 \[[@CR156]\]Inclusion of diabetesTamaki et al. 2009 \[[@CR157]\]No obesity dataTamaki et al. 2011 \[[@CR158]\]No obesity dataTawfig et al. 2015 \[[@CR159]\]No comparisonTeles et al. 2012 \[[@CR160]\]No comparisonToker et al. 2012 \[[@CR161]\]Not addressing research questionTuter et al. 2007 \[[@CR162]\]Inclusion of patients with systemic diseaseVardar et al. 2003 \[[@CR163]\]Not addressing research questionVan Dyke et al. 2015 \[[@CR164]\]Not addressing research questionVyas et al. 2000 \[[@CR165]\]Not addressing research questionWahid et al. 2013 \[[@CR166]\]Not addressing research questionWang et al. 2013 \[[@CR167]\]Inclusion of aggressive periodontitisWehmeyer et al. 2013 \[[@CR168]\]Not addressing research questionWei et al. 2010 \[[@CR169]\]No obesity dataWilliams et al. 2007 \[[@CR148]\]No obesity dataWilliams et al. 2009 \[[@CR170]\]Not addressing research questionWilliams et al. 2009 ([@CR171]\]Not addressing research questionWood et al. 2006 \[[@CR172])Not addressing research questionWu et al. 2015 \[[@CR173])Not addressing research questionZare et al. 2014 \[[@CR174])Not addressing research questionZhou et al. 2013 \[[@CR175]\]Inclusion of patients with systemic diseaseZuza et al. 2011 \[[@CR176])No PPD reduction dataTable 4Probing pocket depth (PPD \[mm\]) as primary outcome variableAuthor & yearTotal number of patients\
Age (mean ± SD)\
CountryOutcome after 2 months\
mean (± SD) at baseline -- mean (± SD) at reassessmentOutcome after 3 months\
mean (± SD) at baseline --\
mean (± SD) at reassessmentOutcome after 6 months\
mean (± SD)at baseline -- mean (± SD) at reassessmentOutcome after 12 months\
mean (± SD)at baseline -- mean (± SD) at reassessmentImpact of obesity on the treatment - outcome\
mean -- reduction of PPD (± SD)Al -- Zahrani et al. 2012 \[[@CR8]\]Total number of patients:\
40 (only women)\
Normal-weight: 20\
Obese: 20\
Age:\
Normal-weight: 43.4 (±7.8)\
Obese: 44 (±8.4)\
Country:\
Saudi ArabiaTotal sample:\
2.65 (±0.47) -- 2.44 (±0.41) *p*-value = 0.001n.r.n.r.n.r.Normal-weight:\
0.19 (±0.27)\
Obese:\
0.23 (±0.33)\
*p*-value = 0.663 (n. sig.)Bouaziz et al. 2015 \[[@CR28]\]Total number of patients:\
36\
Normal-weight: 18\
Obese: 18\
Age:\
Range from 22 to 78\
Normal-weight: 51.00 (±13.1)\
Obese: 51.3 (±16.7)\
p-value: n. sig.\
Country:\
Francen.r.Normal-weight: 3.33 (±0.92) -- 2.71 (±0.40)\
*p*-value: n. sig.\
Obese: 3.22 (±0.76) -- 2.78 (±0.55)\
*p*-value: n. sig.Normal-weight: 3.33 (±0.92) 2.45 (±0.53)\
*p*-value \< 0.05\
Obese: 3.22 (±0.76) -- 2.43 (±0.49)\
*p*-value \< 0.05n.r.Summary of Multivariable Analysis\
Results (Coefficient, 95 % Cl):\
△ %PD \> 5mm after 3 months to obese\
(Model 2):\
*p*-value = 0.02\
△ %PD \> 5mm after 6 months to obese\
(Model 2):\
*p*-value = 0.005\
Nb △PD \> 2mm after 3 months to Obese\
(Model 2);\
*p*-value = 0.02\
Nb △PD \> 2mm after 6 months to Obese\
(Model 2);\
*p*-value = 0.06 (n.sig.)Duzagac et al. 2015 \[[@CR29]\]Total number of patients:\
45\
Normal weight patients with periodontitis (CPNW): 15\
Obese patients with periodontitis (CPO):\
15\
Normal weight periodontally healthy control subjects (PHNW): 15\
Age:\
Range from 28 to 52\
CPNW: 41.06 (±7.10)\
CPO: 40.66 (±7.98)\
PHNW: 39.66 (±6.53)\
*p*-value: n. sig.\
Country:\
Turkeyn.r.CPNW: 3.19 (±0.38) --2.51 -- (±0.06)\
*p*-value = 0.001\
CPO: 4.10 (±0.50) -- 2.55 (±0.45)\
*p*-value = 0.001n.r.n.r.Number of sites with PD \< 4 mm:\
Baseline:\
CPO: 1706\
CPNW: 1766\
3 months:\
CPO: 2214\
CPNW: 2206\
% of sites with PD \< 4 mm:\
Baseline:\
CPO: 75.4\
CPNW: 77.9\
3 months:\
CPO: 97.9\
CPNW: 97.3\
Similar clinical healing;\
(n. sig.)Number of sites with PD ≥ 4 mm:\
Baseline:\
CPO: 556\
CPNW: 502\
3 months:\
CPO: 48\
CPNW: 32\
% of sites with PD ≥ 4 mm:\
Baseline:\
CPO: 48\
CPNW: 22.1\
3 months:\
CPO: 2.1\
CPNW: 2.7\
Similar clinical\
healing;\
(n. sig.)Eldin et al. 2013 \[[@CR30]\]Total number of patients:\
26\
Overweight: 12\
Obese: 14\
Age:\
Range from 35 to 48\
Country:\
Egyptn.r.Overweight: 0.6 (±1.29) -- 0.75 (±2.12)\
*p*-value: n.r.\
Obese: 3.15 (±2.43) -- 1.59 (±2.34)\
*p*-value: n.r.n.r.n.r.Overweight:\
0.784\
Obese:\
0.209\
*p*-value = 0.326 (n. sig.)Gonçalves et al. 2015 \[[@CR31]\]Total number of patients:\
39\
Without obesity: 21\
With obesity: 18\
Age:\
Without obesity: 48.4(±9.5)\
With obesity: 48.8 (±5.9)\
p-value= 0.85 (n. sig.)\
Country:\
Braziln.r.Without obesity: 3.4 (±0.6) -- 3.0 (±0.5)\
*p*-value: sig.\
With obesity: 3.6 (±0.6) -- 3.3 (±0.6)\
*p*-value: sig.Without obesity:\
3.4 (±0.6)- 2.7 (±0.6)\
*p*-value: sig.\
With obesity:\
3.6 (±0.6) -- 3.0 (±0.5)\
*p*-value: sig.n.r.Without obesity\
Full-mouth sites:\
0-3 months: 0.44 (±0.06)\
0-6 months: 0.73 (±0.07)\
Initially moderate sites\
(PD 4-6mm):\
0-3 months: 0.87 (±0.12)\
0-6 months: 1.38 (±0.14)\
Initially deep sites\
(PD ≥ 7mm):\
0-3 months: 1.86 (±0.25)\
0-6 months: 3.00 (±0.23)With obesity\
Full-mouth sites:\
0-3 months: 0.30 (±0.06)\
0-6 months: 0.54 (±0.07)\
Initially moderate sites\
(PD 4-6mm):\
0-3 months: 0.70 (±0.13)\
0-6 months: 1.10 (±0.15)\
Initially deep sites\
(PD ≥ 7mm):\
0-3 months: 1.22 (±0.26)\
0-6 months: 2.30 (±0.24)*p*-value\
(\<0.05)\
0.08\
0.04\
0.31\
0.16\
0.07\
0.04Gonçalves et al. 2015 \[[@CR32]\]Total number of patients:\
40\
Non-obese: 20\
Obese: 20\
Age:\
Non-obese: 48.5 (±9.3)\
Obese: 50.0 (±4.5)\
p-value = 0.52 (n. sig.)\
Country:\
Braziln.r.Non-obese: 3.4 (±0.6) -- 2.9 (±0.6)\
*p*-value: sig.\
Obese: 3.6 (±0.6) -- 3.3 (±0.5)\
*p*-value: sig.Non-obese: 3.4 (±0.6) -- 2.7 (±0.6)\
*p*-value: sig.\
Obese: 3.6 (±0.6) -- 3.0 (±0.5)\
*p*-value: sig.Non-obese: 3.4 (±0.6) -- 2.6 (±0.6)\
*p*-value: sig.\
Obese: 3.6 (±0.6) -- 2.9 (±0.4)\
*p*-value: sig.Mean PPD values (± SD):\
After 3 months:\
Non-obese: 2.9 (±0.6)\
Obese: 3.3 (±0.5)\
*p* = 0.25 (n. sig.)\
After 6 months:\
Non-obese: 2.7 (±0.6)\
Obese: 3.0 (±0.5)\
*p* = 0.04\
After 12 months:\
Non-obese: 2.6 (±0.6)\
Obese: 2.9 (±0.4)\
*p* = 0.03Lakkis et al. 2011 \[[@CR33]\]Total number of patients:\
30\
Surgery: 15\
Control: 15\
Age:\
Surgery: 45.6 (±11.1)\
Control: 48.5 (±12.0)\
p-value = 0.778 (n. sig.)\
Country:\
USA (Cleveland, Ohio)4-6 weeks after therapy!\
Surgery:\
2.6 (±0.6) -- 2.2 (±0.5)\
*p*-value \< 0.001\
Control:\
3.1 (±0.8) -- 2.8 (±0.7)\
*p*-value \< 0.001n.r.n.r.n.r.Surgery:\
0.45\
Control:\
0.28\
*p*-value = 0.007Suvan et al. 2014 \[[@CR34]\]Total number of patients:\
260\
Normal: 112\
Overweight: 93\
Obese: 55\
Age:\
Normal: 46.30 (±8.38)\
Overweight: 47.27 (±8.93)\
Obese: 46.55 (±6.87)\
*p*-value = 0.701 (n. sig.)\
Country:\
Great Britain (London)Summary of univariable GEE Analysis Results (Coefficient, 95 % Cl):\
BMI \[kg/m^2^\] to PPD at 2 months\
*p*-value = 0.055\
Overweight to PPD at 2 months\
*p*-value = 0.372 (n. sig.)\
Obese to PPD at 2 months\
*p*-value = 0.064 (n. sig.)\
Summary of Multivariable GEE Analysis Results (Coefficient, 95 % Cl):\
BMI \[kg/m^2^\] to PPD at 2 months\
*p*-value = 0.013\
Overweight to PPD at 2 months\
*p*-value = 0.63 (n. sig.)\
Obese to PPD at 2 months\
*p*-value = 0.031n.r.n.r.n.r.BMI and obesity were sig. associated with mean PPD after 2 months. (*p* = 0.055)\
Overweight was not sig. associated with PPD after 2 months (*p* = 0.372)\
BMI had a stat. sig. linear relationship with mean PPD after 2 months (*p* = 0.013).\
Overweight compared with normal BMI status did not demonstrate a stat. sig. association with mean PPD after 2 months (p = 0.63). Obesity compared with normal BMI status remained a stat. sig. predictor of mean PPD (*p* = 0.031) at 2 months in the same multivariable model.*CI* confidence interval, *CPNW* normal weight patients with periodontitis, *CPO* obese patients with periodontitis, *kg* kilogram, *m* meter, *mm* millimeter, *Nb ∆ PD* number of improving PD, *n.r.* not reported, *PD* probing depth, *PHNW* normal weight periodontally healthy control subjects, *PPD* periodontal pocket depth, *p* probability, *SD* standard deviation, *(n.) sig.* (not) significant, *stat.* statistically, *WHO* world health organisationTable 5Definition of periodontitis, periodontal assessment and definition of smokingAuthor & yearDefinition of chronic periodontitisPeriodontal assessmentSmokersAl -- Zahrani et al. 2012 \[[@CR8]\]≥ 20 teeth,\
CAL ≥ 3 mm at ≥ 30 of the sites\
(generalized moderate/severe chronic periodontits)Full-mouth periodontal examination on all teeth excluding 3rd molars and partially erupted teethSmokers excludedBouaziz et al. 2015 \[[@CR28]\]≥ 12 teeth,\
≥ 30 % of sites with CAL ≥ 3 mm\
(moderate-to-severe generalized chronic periodontitis)Full-mouth clinical measurements included the following:\
1) PI,\
2) BOP,\
3) PD (mm),\
4) CAL (mm),\
PI, BOP, PD, and CAL measurements were performed using a manual periodontal probe at 6 sites per tooth,\
PD was defined as the distance from the free gingival margin to the bottom of the pocket/sulcus, and CAL was defined as the distance from the cemento-enamel junction to the bottom of the pocket/sulcusNon-smoker or former smoker since ≥ 5 yearsDuzagac et al. 2015 \[[@CR29]\]≥ 20 teeth,\
PD ≥ 4 mm in ≥ 30 % of periodontal sites,\
BOP in ≥ 50 % of periodontal sites,\
interproximal CAL \> 2 mm in ≥ 20 % of periodontal sites,\
radiographic evidence of bone loss, as described\
by Armitage \[[@CR177]\]A Williams-type periodontal probe (UNC15, Hu-Friedy, Chicago, IL, USA) was used for the measurements of periodontal parameters, including PI (Silness--Löe) \[[@CR178]\], GI (Löe--Silness) \[[@CR179]\], BOP, PD and CAL,\
all clinical periodontal measurements were performed at 6 sites per tooth (mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual and distolingual),\
excluding third molarsSmokers excludedEldin et al. 2013 \[[@CR30]\]n.r.\
(chronic periodontitis)Full-mouth,\
4 sites per tooth (mesio-buccal, mid-buccal, disto-buccal, mid-lingual) around each toothn.r.Gonçalves et al. 2015 \[[@CR31]\]≥ 15 teeth excluding 3rd molars and teeth with advanced decay indicated for exodontia,\
\>30 % of the sites with concomitant PD and\
CAL ≥4 mm and a minimum of 6 teeth distributed in the different quadrants presenting at least one site with PD and CAL ≥ 5 mm and BOP at baseline\
(generalized chronic periodontitis)6 sites per tooth on all teeth excluding 3rd molars (distance between the gingival margin and the bottom of the sulcus/pocket \[mm\])Smokers excludedGonçalves et al. 2015 \[[@CR32]\]≥ 15 teeth excluding 3rd molars and teeth with advanced decay indicated for exodontia,\
\>30 % of the sites with concomitant PD and\
CAL ≥ 4 mm and a minimum of 6 teeth distributed in the different quadrants presenting at least one site with PD and CAL ≥ 5 mm and BOP at baseline\
(generalized chronic periodontitis)6 sites per tooth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual) excluding third molars, with a manual periodontal probe (UNC15, Hu-Friedy, Chicago, IL, USA)Current smokers excluded, smoking within the past 10 years excludedLakkis et al. 2011 \[[@CR33]\]≥ 20 teeth,\
mean CAL ≥ 2 mm\
(chronic periodontitis)6 sites per toothn.r.Suvan et al. 2014 \[[@CR34]\]PD \> 5 mm and marginal alveolar bone loss \> 30 % with \> 50 % of the teeth affected\
(generalized severe periodontitis)6 sites per tooth on all teeth presentNormal-group = 47 % smokers\
Overweight-group = 25 % smokers\
Obese-group = 15 % smokers\
*p* - value = 0.045 (sig. on *p* ≤ 0.05)*BoP* bleeding on probing, *CAL* clinical attachment level, *GI* gingival index, *mm* millimeter, *n.r.* not reported, *p* probability, *PD* probing depth, *PI* plaque index, *sig.* significantTable 6Definition of obesity and systemic examinationAuthor & yearDefinition of obesitySystemic examinationAl -- Zahrani et al. 2012 \[[@CR8]\]Normal-weight: BMI: 18.5 to \< 25 kg/m^2^\
Obese: BMI ≥ 30 kg/m^2^Weight in kilograms and height in meters were measured;\
BMI: (weight/height^2^ \[kg/m^2^\])Bouaziz et al. 2015 \[[@CR28]\]Normal-weight: BMI ≥ 18.5 kg/m^2^ and ≤ 25 kg/m^2^\
Obese: BMI ≥ 30 kg/m^2^Weight (kg), height (m), waist/hip circumferences (cm)\
weight was obtained using a calibrated scale,,\
height was measured using a measuring board,\
BMI: (weight/height^2^ \[kg/m^2^\]),\
waist measurements were taken at the level of the umbilicus (cm)\
hip measurements were taken at the greatest circumference with a measuring tape,\
WHR: ratio of waist to hip circumferenceDuzagac et al. 2015 \[[@CR29]\]Normal-weight (CPNW): n.r.\
Obese (CPO): BMI ≥ 30 % and WHR \> 0.95 for males and 0,80 for femalesOne trained examiner performed all anthropometric measurements:\
weight (kg), height (m), waist (cm), hip (cm),\
BMI: (weight/height^2^ \[kg/m^2^\]),\
WHR: ratio of waist to hip circumference,\
anthropometric measurements were repeated before the final follow-up visit to assess\
whether there was any change in BMI or WHREldin et al. 2013 \[[@CR30]\]Overweight: BMI: 25-29.9 kg/m^2^\
Obese: BMI ≥ 30 kg/m^2^\
According to the WHO (3)n.r.Gonçalves et al. 2015 \[[@CR31]\]Without obesity: BMI 20-29.9 kg/m^2^ and\
WHR \< 0.85 for females and \< 0.9 for males\
With obesity: BMI ≥ 30 kg/m^2^ and \< 40 kg/m^2^ and\
WHR ≥ 0.85 for females and WHR ≥ 0.9 for malesBMI: (weight/height^2^ \[kg/m^2^\])\
WHR: ratio of waist to hip circumferenceNon-obese: BMI: 20-24.9 kg/m2 and WHR below that determined for obesity (i.e. WHR \< 0.85 for women and\
WHR \< 0.90 for men) (World Health Organization 2008)\
Obese: BMI ≥ 30 and \< 40 kg/m2 and concomitant WHR\
≥0.85 for women and WHR ≥ 0.90 for men.One trained examiner performed\
all anthropometric measurements:\
weight (kg), height (m), waist (cm) and\
hip circumferences (cm)\
BMI: (weight/height^2^ \[kg/m^2^\]),\
WHR: ratio of waist to hip circumference,\
anthropometric measurements were reassessed at all follow-up visits to verify that the patients did not change their obese or non-obese status during the course of the studyLakkis et al. 2011 \[[@CR33]\]Control: obese (BMI ≥ 30 kg/m^2^)\
Did not have the bariatric surgery nor did they lose weight to serve as a control group\
Surgery: obese (BMI ≥ 30 kg/m^2^) and\
≥ 40 % loss of their excess weight at ≥ 6 months after bariatric surgeryBMI: (weight/height^2^ \[kg/m^2^\])\
Percentage of weight loss after BSSuvan et al. 2014 \[[@CR34]\]Normal: BMI: 18.5-24.99 kg/m^2^\
Overweight: BMI: 25-29.99 kg/m^2^\
Obese: BMI ≥ 30 kg/m^2^BMI: (weight/height^2^ \[kg/m^2^\])\
Based upon height and weight of the individual measured with a wall-mounted height measure and mechanical scales*BF* body fat, *BMI* body mass index, *BS* bariatric surgery, *cm* centimeter, *CPNW* normal weight patients with periodontitis, *CPO* obese patients with periodontitis, *HDL* high-density lipoprotein, *kg* kilogram, *m* meter, *n. r.* not reported, *WC* waist circumference, *WHO* world health organization, *WHR* waist-hip-ratioTable 7Non-surgical periodontal treatment, treatment time and limitationsAuthor & YearNon-surgical periodontal treatmentTreatment time;\
periodontal maintenanceLimitationsAl -- Zahrani et al. 2012 \[[@CR8]\]Oral hygiene instructions,\
SRP performed by one operatorn.r.;\
n.r.n.r.Bouaziz et al. 2015 \[[@CR28]\]Oral hygiene instructions (brushing technique: Bass technique, use of interproximal hygiene devices, CHX mouthwash (0.12 %) twice a day for 7 days),\
SRP under local anesthesia using an ultrasonic device and manual curets,\
aim of each session was to remove biofilms and calculus of scaled roots,\
treatment protocol did not include antibiotic treatment,\
all treatments procedures were performed by the same periodontist (WB)2-3 sessions for probing depth (PD) \> 5 mm lasting 1 h each within 7 days;\
Oral hygiene was controlled at each appointment,\
hygiene instructions were repeated if needed\
at the 3-month examination, reinstruction of oral hygiene methods was performed if needed, and residual pockets ≥ 4 mm were systematically scaled and planedDuring the study, two patients dropped out in each group for the following reasons:\
1) two patients migrated;\
2) one missed the 3-month examination;\
3) one missed the final examinationDuzagac et al. 2015 \[[@CR29]\]Oral hygiene instructions,\
all kinds of dental treatments, such as fillings and adjustment of overhanging restorations, were completed immediately after patient enrollment,\
SRP using a reduced Gracey curette set (Gracey, SAS 5-6, SAS 7-8, SAS 11-12, SAS13- 14, Hu-Friedy) with an ultrasonic device (Dentsply/Cavitron, SPS, 30 K, TFI 1000, Dentsply, York, PA, USA) under local anesthesia,\
endpoint of treatment: a smooth tooth surface,\
patients received no adjunctive therapy (local or systemic antibiotics, NSAI, laser, ozonotherapy and mouth rinses),\
an experienced periodontist (EC) performed all treatment procedures\
(SRP, providing oral hygiene instructions and organizing patient recalls)SRP in 4 sequential visits with 2 or 3 days intervals\
completed within 12 days,\
each appointment lasted 45 min;\
all patients received monthly periodontal maintenance, including oral hygiene reinforcement, scaling and polishing as necessary8 were excluded for several reasons\
did not return for 3 months follow-up,\
pregnancy,\
weight lossEldin et al. 2013 \[[@CR30]\]Oral hygiene instructions,\
SRPn.r.;\
periodontal maintenance (re-examination) performed weekly for 3 months after therapyn.r.Gonçalves et al. 2015 \[[@CR31]\]Oral hygiene instructions,\
Supragingival plaque and calculus removal, exodontia, filling overhang removal and provisional restoration as necessary,\
trained periodontist performed SRP with manual curets and ultrasonic device under local anesthesia,\
endpoint for each SRP appointment was "smoothness of the scaled roots."4 to 6 appointments lasting ≈ 1 h each,\
periodontal therapy was completed in 14 days;\
periodontal maintenance at 3 and 6 months after\
therapy3 patients from the group without obesity and 6 from the group with obesity did not return for the 3-months follow-up visit and were excluded.Author & YearNon-surgical periodontal treatmentTreatment time; periodontal maintenanceAdverse eventsGonçalves et al. 2015 \[[@CR32]\]Oral hygiene instructions regarding brushing technique and\
use of dental floss,\
supragingival plaque and calculus removal, exodontia, provisional restoration and filling overhang removal, as necessary,\
trained periodontist performed SRP using manual curettes (Hu-Friedy, Chicago, IL, USA) and ultrasonic device (Cavitron Select SPC, Dentsply professional, York, PA, USA), under local anaesthesia,\
without use of local and/or systemic antimicrobials.4 to 6 appointments lasting approximately 1 h each, Periodontal therapy completed within 2 weeks;\
All patients received periodontal maintenance\
every 3 months post-therapyThere were no patient and sampled site dropouts during the course of the study.Lakkis et al. 2011 \[[@CR33]\]Oral hygiene instructions,\
SRPn.r.;\
n.r.n.r.Suvan et al. 2014 \[[@CR34]\]Oral hygiene instructions,\
full-mouth mechanical periodontal debridement with hand and ultrasonic instruments performed with local anesthesia by the same clinicianWithin a 24-h period of time;\
n.r.No individuals in the sample had missing data for any of the covariates listed in this study.*CHX* chlorhexidine, *min* minute, *mm* millimeter, *n.r.* not reported, *PD* pocket depth, *SRP* scaling and root planing

The quality of the included studies was assessed through the Newcastle-Ottawa Quality Assessment Scale (Table [8](#Tab8){ref-type="table"}).Table 8Newcastle -- Ottawa Quality Assessment ScaleStars represent "awards" for each quality item and serve as a quick visual assessment. A maximum of one 'star' for each item within the 'Selection'/'Exposure' categories and a maximum of two 'stars' for 'Comparability' can be awarded

Results {#Sec8}
=======

Selection of studies {#Sec9}
--------------------

Initially, 159 studies were identified by electronic search by the two reviewers (FAG, PRS). Full text analysis of the 18 potentially qualified reports led to exclusion of 10 other studies. Additional five titles \[[@CR23]--[@CR27]\] were identified by hand search but after full text analysis, all these articles had to be excluded based on the inclusion and exclusion criteria (Table [3](#Tab3){ref-type="table"}). Therefore, eight publications \[[@CR8], [@CR28]--[@CR34]\] from the electronic and hand search fulfilled the criteria. However, it was not possible to compare the raw data so that we had to reduce our analysis to a qualitative analysis. This process is summarized in a flow-chart (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1PRISMA 2009 flow diagram

Summary of studies: characteristics (PICO) {#Sec10}
------------------------------------------

Total number of patients, demographic data, origin of study, outcome measurements 2, 3, 6 and 12 months after therapy and the impact of obesity on the treatment-outcome are summarized in Table [4](#Tab4){ref-type="table"}.

Definition of chronic periodontitis, periodontal assessment and the amount of smokers included are depicted in Table [5](#Tab5){ref-type="table"}.

The definition of obesity and systemic examination were summarized in Table [6](#Tab6){ref-type="table"}. Non-surgical periodontal treatment, treatment time, periodontal maintenance and limitations are shown in Table [7](#Tab7){ref-type="table"}.

Population {#Sec11}
----------

Of the eight finally analyzed studies, clinical trials comprised 516 participants. One study \[[@CR8]\] enrolled only women. The prevalence of smoking among male patients affected with periodontitis was so high that Al-Zahrani and co-workers \[[@CR8]\] were unable to correct for smoking in the male population. Accordingly, only women were included in their study. Overall the studies comprised between 26 up to 260 subjects (Table [4](#Tab4){ref-type="table"}).

The inclusion criteria "age" was defined in all but one study \[[@CR30]\]. Three investigations \[[@CR28], [@CR33], [@CR34]\] defined the age ≥18 years. The other studies defined a minimum age of 30 years \[[@CR31], [@CR32]\] or 35 years \[[@CR8]\]. Duzagac et al. defined an age range from 25 to 55 years (Table [4](#Tab4){ref-type="table"}).

Suvan et al. \[[@CR34]\] included smokers into their study. Lakkis et al. \[[@CR33]\] and Eldin et al.(30\] did not mention the smoking status of the patients. All other studies \[[@CR8], [@CR28], [@CR29], [@CR31], [@CR32]\] excluded smokers (Table [5](#Tab5){ref-type="table"}).

Patients with diabetes, another important modifier of periodontal health or disease \[[@CR35]\] were excluded in seven studies \[[@CR8], [@CR28]--[@CR32], [@CR34]\]. Lakkis et al. \[[@CR33]\] did not report the presence or absence of diabetes.

Intervention/Comparison {#Sec12}
-----------------------

Each paper described the periodontal intervention as a non--surgical therapy. All studies \[[@CR8], [@CR28]--[@CR34]\] applied scaling and root planing. Ultrasonic instruments and/or hand instruments were used in all studies (Table [7](#Tab7){ref-type="table"}).

Two papers (8,34\] reassessed the PPD 2 months after therapy. Two studies \[[@CR29], [@CR30]\] reassessed their patients after 3 months. Another two papers \[[@CR28], [@CR31]\] re-evaluated the patients after 3 and 6 months and one study \[[@CR32]\] reassessed the PPD three, six and 12 months after therapy. Only Lakkis et al. \[[@CR33]\] measured the periodontal pocket depths already 4 to 6 weeks after non-surgical therapy (Table [3](#Tab3){ref-type="table"}). Oral hygiene was instructed additionally to the non--surgical periodontal therapy in all studies (Table [7](#Tab7){ref-type="table"}).

Due to the heterogeneity of the study designs with respect to outcome measures and treatment protocol, as well as variation in study population, sample size, and/or statistical methods, a statistical synthesis of the results of the included studies was not possible. So the authors decided to analyze the papers on a qualitative way \[[@CR22]\]. A meta-analysis was not possible.

Outcome {#Sec13}
-------

Generally obese patients were found to have deeper periodontal pockets at baseline in all studies.

Three \[[@CR8], [@CR29], [@CR30]\] of the eight papers \[[@CR8], [@CR28]--[@CR34]\] reported no major negative impact of obesity on response to periodontal therapy in terms of PPD reduction (mm). Al-Zahrani et al. \[[@CR8]\] assessed the reduction of PPD (mm) comparing obese with normal--weighted women. There was no statistically significant effect of obesity on treatment outcome. Duzagac et al. \[[@CR29]\] assessed the clinical response to non-surgical periodontal treatment, according to the severity of periodontitis based on probing depth \< 4 mm vs. ≥ 4 mm. Patients with and without obesity showed similar clinical healing in terms of percentage and number of sites with probing depth \< 4 mm and ≥ 4 mm. So they failed to show an effect of obesity on the treatment outcome dependent on the severity of the disease. Eldin et al. \[[@CR30]\] also found no effect when comparing an overweight group with an obese group. The difference between the groups in reduction of PPD was not significant (Table [4](#Tab4){ref-type="table"}).

Five \[[@CR28], [@CR31]--[@CR34]\] of the eight papers showed a negative effect of obesity on the healing after non-surgical periodontal therapy. Bouaziz et al. \[[@CR28]\] revealed that normal-weight patients had a better response to periodontal treatment than obese patients. This effect was specially observed for moderate-to-deep pockets. This fact suggests that the more severe the periodontitis the more pronounced is the negative effect of obesity on periodontal treatment outcome. They showed in the multivariate analysis that obesity was significantly associated with percentage changes of PD \> 5 mm and numbers of improving sites (p ≤ 0.05). In the univariate analysis all periodontal parameters improve more in patients suffering from more severe periodontitis at baseline. Other patient characteristics, like age, sex, obesity, and WHR, were not associated with periodontal parameter changes. Gonçalves et al. \[[@CR31]\] showed that patients with obesity and chronic periodontitis had a lower PDD reduction than patients without obesity. The measurement of the reduction in PPD (mm) at full-mouth sites showed after 3 months a not statistically significant difference (*p* = 0.08) between the obese group compared to the group without obesity. However after 6 months there was a statistically significant difference (*p* = 0.04). At this time point, especially deep sites (PPD ≥ 7 mm) showed a significantly better result in the group without obesity (*p* = 0.04). Another study of Gonçalves et al. \[[@CR32]\] reported that patients with obesity had a significantly greater mean PD (6 months *p*-value = 0.04, 12 months *p* value = 0.03) than patients without obesity at six and 12 months post-therapy. The data of a study by Suvan et al. \[[@CR34]\] corroborated these findings and showed that obesity was an independent impact value of poorer periodontal treatment outcome 2 months after therapy. The extent of the association between poorer periodontal treatment and obesity was similar to that of smoking (*p* = 0.02). They worked with 260 patients. This secondary analysis consisted of individuals participating in five clinical studies of non-surgical periodontal therapy over a 7-year period. Lakkis et al. \[[@CR33]\] selected 30 patients who were obese; 15 of them had previously undergone bariatric surgery, whereas the other half (*n* = 15) did not loose any weight and served as a control group. The bariatric surgery group reached a statistically significant greater mean PPD reduction (0.45 mm versus 0.28 mm) compared with the control (no surgery) group (*p* = 0.007; Table [4](#Tab4){ref-type="table"}).

Limitations {#Sec14}
-----------

Some patients could not be reviewed or discontinued the study for personal reasons \[[@CR28], [@CR29], [@CR31]\]. Weight loss and pregnancy were additional reasons to be excluded in the study of Duzagac et al. \[[@CR29]\] (Table [7](#Tab7){ref-type="table"}).

The quality of the included studies was evaluated through the Newcastle-Ottawa Quality Assessment Scale (Table [8](#Tab8){ref-type="table"}).

Discussion {#Sec15}
==========

This review focused on obesity and the outcome after non-surgical periodontal therapy and has shown that currently there is no really robust scientific evidence to reach solid conclusions and recommendations.

Three papers \[[@CR8], [@CR29], [@CR30]\] were found, which did not find any statistically significant negative impact of obesity on the response to non-surgical periodontal therapy, whereas five papers \[[@CR28], [@CR31]--[@CR34]\] showed the opposite, i.e. a clearly negative influence of obesity on the treatment outcomes.

With regard to the quality of evidence, seven included papers \[[@CR8], [@CR28], [@CR29], [@CR31]--[@CR34]\] reported some limitations.

Al-Zahrani et al. \[[@CR8]\] included only women. Gonçalves and co-workers \[[@CR31]\] did not consistently apply the accepted definitions of overweight and obesity, but rather included the waist-to-hip-ratio (WHR) for their definitions, probably leading to inclusion of patients with a BMI inferior to 30 kg/m^2^ into the obesity group. Thus the results are difficult to interpret and compare with the other studies and are therefore not applicable for patients with a BMI ≥40 kg/m^2^ \[[@CR31]\]. Nonetheless, these studies still show a clearly better tendency with regard to the treatment response for patients without obesity as defined in their study. Lakkis et al. \[[@CR33]\] chose another interesting way to find an impact of obesity on the outcome of non-surgical periodontal treatment. They compared obese people who had undergone bariatric surgery (BS) with obese who did not. After weight loss in the BS group, a reduction in total adipocytes might have resulted in a decrease in adipokines and pro-inflammatory mediators released by those adipose cells. This systemic inflammatory reduction might have played a role in reducing the insulin resistance resulting in a better outcome after periodontal therapy as suggested by the authors \[[@CR33]\]. Some limitations in the specific profile of the obese patients (nondiabetic, non-smoker) in the paper of Bouaziz et al. (28) may restrict the extrapolation of the results to the whole obese population. Furthermore, the small sample size may also limit the power of this study. Duzagac et al. \[[@CR29]\] failed to include a control group of periodontally healthy controls with obesity. Additionally the mean periodontitis parameters were within the limits of "moderate" periodontitis, and the WHR and BMI values of these obese patients were predominantly below those characterizing morbid obesity. So, the results of this study may not be extrapolated to those with severe periodontitis or morbid obesity. The second included study of Gonçalves and co-workers \[[@CR32]\] assumes that the high inter-patient variance in adipokine levels may reduce the statistical power to detect treatment effects, as previously reported. The results presented by Suvan et al. \[[@CR34]\] may have been influenced by study limitations linked with unequal numbers in BMI categories and sample size. In addition, there may have been limitations with regard to the interpretation associated with the *post hoc* secondary analysis experimental design, although variation in clinical assessment and treatment was minimized by examiner and treatment clinician stability. This study did not constitute a higher level of evidence in the context of evidence-based health care levels of scientific evidence \[[@CR34]\].

Overall, obesity is an obvious, visible stigma so that the studies cannot be considered blinded. This may be another possible bias in each of the studies.

Five studies \[[@CR8], [@CR28], [@CR29], [@CR31], [@CR32]\] excluded smokers. Since smoking influences periodontal health these studies are biased \[[@CR9]\] and may not be fully representative for the typical overall population. Overall it appears, however, that a positive effect of normal weight is present in non-smokers \[[@CR28], [@CR31], [@CR32]\] and in smokers \[[@CR34]\].

As mentioned before, the included studies differed in statistical methods, populations, sample sizes, definition of chronic periodontitis, definition of obesity, time of outcome measurement, smoking status, periodontal assessment and non-surgical periodontal therapy. Therefore, it was not only impossible to perform a meta-analysis but also draw clear conclusions.

Nonetheless there is a consensus in the studies that obesity is associated with different baseline PPD levels. The large cohort in the study of Suvan et al. \[[@CR34]\] and the long term results of Gonçalves et al. \[[@CR31], [@CR32]\] may lead to the conclusion that obesity is an important negative factor which influences non-surgical periodontal therapy.

In summary, all studies \[[@CR8], [@CR28], [@CR29], [@CR31]--[@CR34]\] included in this review validated the efficacy of non-surgical periodontal therapy, except the study of Eldin and co-workers \[[@CR30]\] who did not report any efficacy of the therapy (Table [3](#Tab3){ref-type="table"}). Clinically, it appears obvious that a therapy is necessary to reach periodontal health independent of the patient's body mass index.

Because this systematic review provided only moderate evidence that obesity is an important factor for non-surgical periodontal therapy, future prospective cohort studies are needed to confirm these findings \[[@CR36]\]. Such trials should be of high methodological quality. They should control important confounding factors such as smoking status, severity of chronic periodontitis, severity of obesity. Every patient should get the same periodontal treatment and periodontal maintenance. Overall, there is a possibility to solve the research question even though blinding of the examiners to obesity or non-obesity status is not practically possible.

Clinicians should know that obesity may have some influence on periodontal status and are likely to have a negative impact on the clinical outcome of conservative treatment, even if this systematic review found only five \[[@CR28], [@CR31]--[@CR34]\] out of eight papers \[[@CR8], [@CR28]--[@CR34]\] corroborating the influence of obesity on the clinical periodontal outcome focusing on PPD as surrogate parameter for periodontal healing.

Clinicians might consider a weight reduction diet as an additional treatment for periodontal health with a positive effect expected after 6 and 12 months \[[@CR31], [@CR32]\]. Also it should not be neglected that weight control has substantial other beneficial health effects which on their own justify such a recommendation.

Conclusion {#Sec16}
==========

This systematic review indicates a possible negative relationship between obesity and poorer treatment outcome in obese patients after non-surgical therapy based on the results of five out of eight studies. Three of these studies denied an impact of obesity on the treatment. The potentially inferior healing response could be based on pathophysiological inflammatory models.

Baseline levels showed also a poorer periodontal health in patients with obesity compared with non-obese patients.

No study found any better dental health parameters in obese than in non-obese individuals, and although dental health may not be the most important target for arriving at a near normal body weight, a person who can keep his or her body weight near normal might, in addition to all other established health benefits, count on having better periodontal health than if they are obese.
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